NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Vascudyne

Vascudyne

Private
Saint Paul, MinnesotaHealthcare & Life Scienceshttps://vascudyne.com/

Last Round

Grant

Jun 1, 2025

Total Funding Raised

$14M

Company Overview

Vascudyne is a biotechnology company that develops a bioengineered tissue platform designed to create implantable blood vessels and heart valves for cardiovascular care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

regenerative medicinetissue engineeringheart valve replacementacellular tissue graftvascular graftoff-the-shelf implanthemodialysis access graftbiological implantregenerative implantpediatric heart valveimplantable scaffoldclinical-stage medtechsoft tissue repairClass III medical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vascudyne Comps

Public and private peers based on sector, stage, and business model.

Vascudyne comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Vascudyne Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 1, 2025
Series ADec 2, 2021

Key People

Founding team and executive leadership

Zeeshan Syedain

Chief Executive Officer, Chief Science Officer

Executive Team

Vascudyne Investors

Notable investors and investment history

Vascudyne investors
InvestorRounds
Congressionally Directed Medical Research ProgramsGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2025

    Monthly visitors increased 83% MoM.

  • Jun 1, 2025

    $4M grant received from Congressionally Directed Medical Research Programs.

Vascudyne Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vascudyne Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vascudyne's valuation, stock price, and market status.

Firmographic Details

HeadquartersSaint Paul, Minnesota
Employee Range12
Year Founded2014
Last FundingJun 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.